Morphine and hydromorphone infusions of 6 or more (average 25.75) days in duration were used with increasing frequency (up to 7%) by our oncology inpatients. Eighty-six percent of the 135 inpatients we reviewed realized good pain control with dose rates up to 700 morphine-equivalent (ME) mg/h. Local toxicity occurred on only 10 occasions. Systemic side effects secondary to the infusion were reported 75 times and were generally readily reversed. Myoclonus was seen in 11% of our patients at dose rates as low as 60–90 ME mg/h. Adjuvant therapies were not used as frequently as might be warranted. We believe that narcotic infusions, particularly subcutaneous ones, are safe and effective. Further prospective trials are needed to clarify how they should be combined with other therapies to control cancer pain that is poorly responsive to narcotics, and to better understand the etiology and management of serious side effects.
Get full access to this article
View all access options for this article.
References
1.
HolmesA.H.Morphine iv infusion for chronic pain. Drug Intell Clin Pharm1978; 12: 556–7.
2.
EnsworthS.Morphine iv infusion for chronic pain. Drug Intell Clin Pharm1979; 13: 297.
3.
BeaverW.T.Management of cancer pain with parenteral medication. JAMA1980; 244: 2653–7.
4.
FraserD.G.Intravenous morphine infusion for chronic pain. Ann Int Med1980; 93: 781–2.
5.
MiserA.W., MiserJ.S., ClarkB.S.Continuous intravenous infusion of morphine sulphate for control of severe pain in children with terminal malignancy. J Pediatrics1980; 96: 930–2.
6.
RutterP.C., MurphyF., DudleyH.A.F.Morphine: controlled trial of different methods of administration for postoperative pain relief. Brit Med J1980; 280: 12–13.
7.
DeChristoforoR., CordenB.J., HoodJ.C., NarangP.K., MagrathI.T.High-dose morphine infusion complicated by chlorobutanol-induced somnolence. Ann Int Med1983; 98: 335–6.
8.
AdamsJ.D., DiehlL.F., WilsonJ.P.Ambulatory use of high-dose intravenous morphine for severe pain. Drug Intell Clin Pharm1984; 18: 138–40.
9.
CitronM.L., Johnston-EarlyA., FossieckB.E., KrosnowS.H., FranklinR., SpagnoloS.V., CohenM.H.Safety and efficacy of continuous intravenous morphine for severe cancer pain. Amer J Med1984; 77: 199–204.
10.
LatimerE.Managing cancer pain. Can Fam Physician1984; 30: 429–36.
11.
BriggsG.G., BermanM.L., LangeS., RikerJ., RettenmaierM., DiSaiaP.Morphine: continuous intravenous infusion versus intramuscular injections for postoperative pain relief. Gynecologic Oncology1985; 22: 288–93.
12.
PortenoyR.K., MoulinD.E., RogersA., InturrisiC.E., FoleyK.M.Iv infusion of opioids for cancer pain: clinical review and guidelines for use. Cancer Treat Rep1986; 70: 575–81.
13.
PortenoyR.K.Continuous intravenous infusion of opioid drugs. Med Clin North America1987; 71: 233–41.
RussellP.S.B.Analgesia in terminal malignant disease. Brit Med J1979; 1: 1561.
16.
WrightB.M., CallanK.Slow drug infusions using a portable syringe driver. Brit Med J1979; 2: 582.
17.
HutchinsonH.T., LeedhamG.D., KnightA.M.Continuous subcutaneous analgesics and antiemetics in domiciliary terminal care. Lancet1981; 2: 1279.
18.
DicksonRj, RussellP.S.B.Continuous subcutaneous analgesics for terminal care at home. Lancet1982; 1: 165.
19.
MiserA.W., DavisD.M., HughesC.S., MulneA.F., MiserJ.S.Continuous subcutaneous infusion of morphine in children with cancer. Am J Dis Child1983; 137: 383–5.
20.
CampbellC.F., MasonJ.B., WeilerJ.M.Continuous subcutaneous infusion of morphine for the pain of terminal malignancy. Ann Int Med1983; 98: 51–2.
21.
BrueraE.D., ChadwickS., BacovskyR., MacDonaldN.Continuous subcutaneous infusion of narcotics using a portable disposable pump. J Palliat Care1985; 1: 45–7.
22.
MauskopA.Continuous subcutaneous infusions of narcotics. Management of cancer pain. Syllabus of the postgraduate course. Memorial Sloan-Kettering Cancer Centre, 1985: 189–203.
23.
BadgerC., RegnardC.Pumping in pain relief. Nursing Times1986; 82(28): 52–4.
24.
CoyleN., MauskopA., MaggardJ., FoleyK.M.Continuous subcutaneous infusions of opiates in cancer patients with pain. Oncol Nurs Forum1986; 13: 53–7.
25.
JonesV.A., HanksG.W.New portable infusion pump for prolonged subcutaneous administration of opioid analgesics in patients with advanced cancer. Brit Med J1986; 292: 1496.
26.
NicholsonH.The success of the syringe driver. Nursing Times1986; 82(28): 49–51.
27.
VentafriddaV., SpoldiE., CaraceniA., TamburiniM., DeConnoF.The importance of continuous subcutaneous morphine administration for cancer pain control. Pain Clinic1986; 1: 47–55.
28.
BrueraE., BrenneisC., MichaudM., ChadwickS., MacDonaldR.N.Continuous sc infusion of narcotics using a portable disposable device in patients with advanced cancer. Cancer Treat Rep1987; 71: 635–7.
29.
BrueraE., BrenneisC., MacDonaldR.N.Continuous sc infusion of narcotics for the treatment of cancer pain: an update. Cancer Treat Rep1987; 71: 953–8.
30.
AdelhardtJ., CoyleN., FoleyK.M.Subcutaneous opioid infusions in advanced cancer patients. Abstract. J Pain Symp Manag1988; 3: SB.
31.
AtkinsonR.E.Syringe pumps in home care of the terminally ill. Abstract. J Palliat Care1988; 4: 67.
32.
BrueraE., BrenneisC., MichaudM., BacovskyR., ChadwickS., EmenoA., MacDonaldN.Use of the subcutaneous route for the administration of narcotics in patients with cancer pain. Cancer1988; 62: 407–11.
33.
KerrI.G., SoneM., DeAngelisC., IscoeN., MackenzieR., SchuellerT.Continuous narcotic infusion with patient-controlled analgesia for chronic cancer pain in outpatients. Ann Int Med1988; 108: 554–7.
34.
MacMillanK., BrueraE., MacDonaldN.Home management of cancer pain with subcutaneous narcotics: results of a three-year experience and guidelines. Abstract. J Palliat Care1988: 4: 79.
35.
McDonaldB.Excellence in pain control by continuous s/c infusion of narcotics. Abstract. J Pain Symp Manag1988; 3: S14.
36.
OliverD.J.Syringe drivers in palliative care: a review. Palliative Med1988; 2: 21–6.
37.
ShiffmanR., SwansonG., BulichR., SmithJ.; Pca delivery of sub-q or iv narcotics for cancer pain in the ambulatory setting: a report of 117 patients. Abstract. J Pain Symp Manag1988; 3: S14.
38.
StoreyP., HillH., St. LouisR, TarverE.Subcutaneous infusions for control of cancer pain and nausea. Abstract. J Pain Symp Manag1988; 3: S13.
39.
VenningM., RogersJ.Continuous subcutaneous infusion: flexible option in symptom control. Aust Nurs J1988; 17: 34–7.
40.
DrexelH., DzienA., SpiegelR.W., LangA.H., BreierC., AbbrederisK., PatschJ.R., BraunsteinerH.Treatment of severe cancer pain by low-dose continuous subcutaneous morphine. Pain1989; 36: 169–76.
41.
MilnerP.C., HarpeR., WilliamsB.T.What do palliative-care workers think about portable syringe drivers. Palliative Med1989; 3: 141–51.
VallnerJ.J., StewartJ.T., KotzanJA, KirstenE.B., HonigbergI.L.Pharmacokinetics and bioavailability of hydromorphone following intravenous and oral administration to human subjects. J Clin Pharmacol1981; 21: 152–6.
47.
NahataM.C., MiserA.W., MiserJ.S., ReuningR.H.Analgesic plasma concentrations of morphine in children with terminal malignancy receiving a continuous subcutaneous infusion of morphine sulfate to control severe pain. Pain1984; 18: 109–14.
48.
AdamsF., CruzL., DeachmanM.J., ZamoraE.Focal subdermal toxicity with subcutaneous opioid infusion in patients with cancer pain. J Pain Symp Manag1989; 4:
BrenneisC., MichaudM., BrueraE., MacDonaldR.N.Local toxicity during the subcutaneous infusion of narcotics (SCIN). A prospective study. Cancer Nursing1987; 10: 172–6.
51.
LevyM.H.Pain management in advanced cancer. Semin Oncol1985; 12: 394–410.
52.
HanksG.W.Antiemetics for terminal cancer patients. Lancet1982; 1: 1410.
53.
StambaughJ.E., DrewJ.The combination of ibuprofen and oxycodone/acetaminophen in the management of chronic cancer pain. Clin Pharmacol Ther1988; 44: 665–9.
